Peltz Stuart Walter 4
4 · PTC THERAPEUTICS, INC. · Filed Jan 11, 2022
Insider Transaction Report
Form 4
Peltz Stuart Walter
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-01-07+16,800→ 39,340 total(indirect: By Spouse) - Sale
Common Stock
2022-01-07$38.52/sh−1,869$72,003→ 78,446 total - Award
Common Stock
2022-01-07+44,000→ 122,446 total - Sale
Common Stock
2022-01-07$38.52/sh−294$11,326→ 22,540 total(indirect: By Spouse) - Award
Stock Option (Right to Buy)
2022-01-07+165,000→ 165,000 totalExercise: $38.10Exp: 2032-01-06→ Common Stock (165,000 underlying) - Award
Stock Option (Right to Buy)
2022-01-07+63,000→ 63,000 total(indirect: By Spouse)Exercise: $38.10Exp: 2032-01-06→ Common Stock (63,000 underlying)
Footnotes (4)
- [F1]Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 6,900 RSUs from a January 6, 2021 grant of 27,600 RSUs.
- [F2]Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
- [F3]Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 990 RSUs from a January 6, 2021 grant of 3,960 RSUs.
- [F4]This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.